Neoadjuvant Chemotherapy in Breast Cancer: Prediction of Pathologic Response With PET/CT and Dynamic Contrast-Enhanced MR Imaging—Prospective Assessment

Radiology - United States
doi 10.1148/radiol.12111177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Radiological Society of North America (RSNA)

Related search

Use of Dynamic Contrast-Enhanced MR Imaging to Predict Survival in Patients With Primary Breast Cancer Undergoing Neoadjuvant Chemotherapy

Radiology
Nuclear MedicineRadiologyImaging
2011English

Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy

Radiology
Nuclear MedicineRadiologyImaging
2009English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Early Metabolic Response Using FDG PET/CT and Molecular Phenotypes of Breast Cancer Treated With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Identification of Biomarkers Including 18fdg-Pet/Ct for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Quantitative Analysis of Clinical Dynamic Contrast-Enhanced MR Imaging for Evaluating Treatment Response in Human Breast Cancer

Radiology
Nuclear MedicineRadiologyImaging
2010English

A Comparison of Near-Infrared Diffuse Optical Imaging and 18f-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

Accuracy of Ultrasonography and Mammography in Predicting Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

American Journal of Surgery
MedicineSurgery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy